Candesartan Cilexetil Patent Expiration
Candesartan Cilexetil was first introduced by Ani Pharmaceuticals Inc
Candesartan Cilexetil Patents
Given below is the list of patents protecting Candesartan Cilexetil, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Atacand |
US5196444 (Pediatric) | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec 04, 2012
(Expired) | Ani Pharms |
| Atacand | US5534534 | Pharmaceutical compositions for oral use and method of preparing them |
Jul 09, 2013
(Expired) | Ani Pharms |
| Atacand |
US5534534 (Pediatric) | Pharmaceutical compositions for oral use and method of preparing them |
Jan 09, 2014
(Expired) | Ani Pharms |
Try Our Curated Drug Screens
Candesartan Cilexetil Generics
Several generic applications have been filed for Candesartan Cilexetil. The first generic version for Candesartan Cilexetil was by Mylan Pharmaceuticals Inc and was approved on May 3, 2013. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on Aug 21, 2023.
Given below is the list of companies who have filed for Candesartan Cilexetil generic.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 32MG | tablet | Prescription | ORAL | AB | Jun 20, 2017 |
| 8MG | tablet | Prescription | ORAL | AB | Dec 4, 2018 |
| 4MG | tablet | Prescription | ORAL | AB | Dec 4, 2018 |
| 16MG | tablet | Prescription | ORAL | AB | Dec 4, 2018 |
2. APOTEX
Apotex Inc has filed for 4 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 8MG | tablet | Discontinued | ORAL | N/A | Jan 10, 2014 |
| 4MG | tablet | Discontinued | ORAL | N/A | Jan 10, 2014 |
| 16MG | tablet | Discontinued | ORAL | N/A | Jan 10, 2014 |
| 32MG | tablet | Discontinued | ORAL | N/A | Jan 10, 2014 |
3. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 8MG | tablet | Prescription | ORAL | AB | Dec 5, 2016 |
| 16MG | tablet | Prescription | ORAL | AB | Dec 5, 2016 |
| 32MG | tablet | Prescription | ORAL | AB | Dec 5, 2016 |
| 4MG | tablet | Prescription | ORAL | AB | Dec 5, 2016 |
4. MYLAN
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 4MG | tablet | Prescription | ORAL | AB | May 3, 2013 |
| 8MG | tablet | Prescription | ORAL | AB | May 3, 2013 |
| 16MG | tablet | Prescription | ORAL | AB | May 3, 2013 |
| 32MG | tablet | Prescription | ORAL | AB | May 3, 2013 |
5. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 16MG | tablet | Prescription | ORAL | AB | Aug 21, 2023 |
| 32MG | tablet | Prescription | ORAL | AB | Aug 21, 2023 |
| 8MG | tablet | Prescription | ORAL | AB | Aug 21, 2023 |
6. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 4 different strengths of generic version for Candesartan Cilexetil. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 32MG | tablet | Prescription | ORAL | AB | Aug 23, 2017 |
| 4MG | tablet | Prescription | ORAL | AB | Aug 23, 2017 |
| 8MG | tablet | Prescription | ORAL | AB | Aug 23, 2017 |
| 16MG | tablet | Prescription | ORAL | AB | Aug 23, 2017 |